Jacquiet et al., 2005 - Google Patents
Regulation of Oestrus ovis (Diptera: Oestridae) populations in previously exposed and naïve sheepJacquiet et al., 2005
- Document ID
- 2208174192021222062
- Author
- Jacquiet P
- Ngoc T
- Nouvel X
- Prevot F
- Grisez C
- Yacob H
- Bergeaud J
- Hoste H
- Dorchies P
- Tabouret G
- Publication year
- Publication venue
- Veterinary immunology and immunopathology
External Links
Snippet
Larvae of Oestrus ovis (Insecta: Diptera: Oestridae) are common parasites of nasal and sinus cavities of sheep and goats. During larval development, a specific immune reaction is initiated by the host with a humoral local and systemic response and the recruitment of …
- 241000283898 Ovis 0 title abstract description 61
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/21—Interferons [IFN]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/164—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Micro-organisms or materials therefrom
- A61K35/74—Bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/0003—Invertebrate antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55588—Adjuvants of undefined constitution
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Meeusen et al. | Cells, cytokines and other molecules associated with rejection of gastrointestinal nematode parasites | |
| Patel et al. | Characterisation of effector mechanisms at the host: parasite interface during the immune response to tissue-dwelling intestinal nematode parasites | |
| Moqbel | Histopathological changes following primary, secondary and repeated infections of rats with Strongyloides ratti, with special reference to tissue eosinophils | |
| Jacquiet et al. | Regulation of Oestrus ovis (Diptera: Oestridae) populations in previously exposed and naïve sheep | |
| Bancroft et al. | Cytokine production in BALB/c mice immunized with radiation attenuated third stage larvae of the filarial nematode, Brugia pahangi. | |
| Silvane et al. | A vaccine based on Kunitz-type molecule confers protection against Fasciola hepatica challenge by inducing IFN-γ and antibody immune responses through IL-17A production | |
| Tarigan et al. | Failure to protect goats following vaccination with soluble proteins of Sarcoptes scabiei: evidence for a role for IgE antibody in protection | |
| Babonazarov et al. | Economic Damage Caused by Scabies Itch Mite, Sarcoptes Scabiei (Acariformes: Sarcoptidae) to the Wool Production of Sheep | |
| Sahoo et al. | Immunization with inflammatory proteome of Brugia malayi adult worm induces a Th1/Th2-immune response and confers protection against the filarial infection | |
| Claerebout et al. | The effect of different infection levels on acquired resistance to gastrointestinal nematodes in artificially infected cattle | |
| Sheng et al. | Th2-related cytokines are associated with Fasciola gigantica infection and evasion in the natural host, swamp buffalo | |
| Eichler | Studies on Onchocerca gutturosa (Neumann, 1910) and its development in Simulium ornatum (Meigen, 1818). 3. Factors affecting the development of the parasite in its vector | |
| Negrão-Corrêa et al. | Expression of IL-4 receptor on non-bone marrow-derived cells is necessary for the timely elimination of Strongyloides venezuelensis in mice, but not for intestinal IL-4 production | |
| Lustigman et al. | CD4+-dependent immunity to Onchocerca volvulus third-stage larvae in humans and the mouse vaccination model: common ground and distinctions | |
| Claerebout et al. | Effects of preventive anthelmintic treatment on acquired resistance to gastrointestinal nematodes in naturally infected cattle | |
| Brossard | The use of vaccines and genetically resistant animals in tick control | |
| Elkington et al. | A blowfly strike vaccine requires an understanding of host–pathogen interactions | |
| EP1363937B1 (en) | Immunomodulating agents from parasitic worms and method for isolation thereof | |
| Remion et al. | Unbalanced Arginine pathway and altered maturation of pleural macrophages in Th2-deficient mice during Litomosoides sigmodontis filarial infection | |
| Jacquieta et al. | Regulation of Oestrus ovis (Diptera: Oestridae) populations in previously exposed and naıve sheep | |
| Angulo-Valadez et al. | Specific IgG antibody responses in Oestrus ovis L.(Diptera: Oestridae) infected sheep: associations with intensity of infection and larval development | |
| FOLKARD et al. | Roles for both CD+ and CD8+ T cells in protective immunity against Onchocerca lienalis microfilariae in the mouse | |
| Flores et al. | Leishmania (L.) infantum chagasi isolated from skin lesions of patients affected by non-ulcerated cutaneous leishmaniasis lead to visceral lesion in hamsters | |
| Williams et al. | Antibody response of the fish Rutilus minus to the metacestode of Ligula intestinalis | |
| DE69935077T2 (en) | IMMUNOMODULATORY FACTORS FOR IMMUNOSUPPRESSIVE AND ANTIALLERGIC TREATMENT |